Vertis

A finding that ertugliflozin produced a 30% drop in heart failure hospitalization risk fell outside the study's primary and secondary end points; here, the drug performed within range of its class, the sodium glucose co-transporter 2 (SGLT2) inhibitors.

Vertis, which completed four years of operations in August, has grown its asset base from around Rs 5,400 crore when it began to about Rs 27,200 crore currently. The InvIT, earlier known as Highway Infrastructure Trust, has 27 projects

Vertis is in advanced talks to buy eight road assets from Megha Engineering, valued at about $800 million including debt.

DunPort Capital Management ("DunPort"), a leading private credit manager, and Vertis Capital Partners ("Vertis"), a UK-based alternative investment firm focused on asset-backed finance and private credit, today announced a strategic long-term partnership.

Welkom bij WordPress. Dit is je eerste bericht. Bewerk of verwijder het, start dan met schrijven!

Reflections On Startup Failure. Product Market Fit. Resilience

That Time I Accidentally Terminated 600 Instances - Otherwise known as "The Zombie Apocalypse"

SingleFile

New exploratory analyses show treatment with the SGLT2 inhibitor ertugliflozin reduced risk for worsening kidney function, dialysis or renal death among adults with type 2 diabetes compared with placebo.In prespecified exploratory analyses presented at th